Share on LinkedInShare on LinkedIn

ARTICLE · 01 DECEMBER 2025

Japanese Government Considers Potential Improvements To Patent Linkage System For Generics

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

The Ministry of Health, Labour and Welfare ("the MHLW") currently lacks sufficient legal experience to assess whether a generic product will...

JapanIntellectual Property

In Short

The Background: The Ministry of Health, Labour and Welfare ("the MHLW") currently lacks sufficient legal experience to assess whether a generic product will, if approved, infringe a third-party patent. Further, Japanese courts do not allow generic companies to obtain a declaratory judgment of noninfringement at the preapproval stage, on the ground that generic companies have no legal interest to seek such relief before the MHLW's approval. Against this background, and in an effort to improve the Japanese patent linkage system, the MHLW published a report proposing the use of a panel of experts to help assess the risk of patent infringement by a generic product.

The Result: The MHLW is preparing to implement, on a trial basis, the expert panel system proposed in the report. Depending on the results of the trial, the MHLW will decide whether to use the panel expert system permanently, which could improve the quality of the approval process for generic

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from